Cargando…
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit conc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035771/ https://www.ncbi.nlm.nih.gov/pubmed/24830987 http://dx.doi.org/10.3390/ph7050621 |
_version_ | 1782318102717923328 |
---|---|
author | Kuntzsch, Matthias Lamparter, Denis Brüggener, Nils Müller, Marco Kienzle, Gabriele J. Reischl, Gerald |
author_facet | Kuntzsch, Matthias Lamparter, Denis Brüggener, Nils Müller, Marco Kienzle, Gabriele J. Reischl, Gerald |
author_sort | Kuntzsch, Matthias |
collection | PubMed |
description | Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit concentration of residual reagent is not reached. Here, we describe the successful development and pharmaceutical validation (for specificity, accuracy and detection limit) of a simplified color spot test on TLC plates. We were able to prove its applicability as a general, time and resources saving, easy to handle and reliable method in daily routine analyzing (18)F-tracer formulations for Kry (in [(18)F]FDG or [(18)F]FECh) or TBA contaminations (in [(18)F]FLT) with special regard to complex matrix compositions. |
format | Online Article Text |
id | pubmed-4035771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-40357712014-05-28 Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals Kuntzsch, Matthias Lamparter, Denis Brüggener, Nils Müller, Marco Kienzle, Gabriele J. Reischl, Gerald Pharmaceuticals (Basel) Article Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit concentration of residual reagent is not reached. Here, we describe the successful development and pharmaceutical validation (for specificity, accuracy and detection limit) of a simplified color spot test on TLC plates. We were able to prove its applicability as a general, time and resources saving, easy to handle and reliable method in daily routine analyzing (18)F-tracer formulations for Kry (in [(18)F]FDG or [(18)F]FECh) or TBA contaminations (in [(18)F]FLT) with special regard to complex matrix compositions. MDPI 2014-05-14 /pmc/articles/PMC4035771/ /pubmed/24830987 http://dx.doi.org/10.3390/ph7050621 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Kuntzsch, Matthias Lamparter, Denis Brüggener, Nils Müller, Marco Kienzle, Gabriele J. Reischl, Gerald Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title | Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title_full | Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title_fullStr | Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title_full_unstemmed | Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title_short | Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals |
title_sort | development and successful validation of simple and fast tlc spot tests for determination of kryptofix(®) 2.2.2 and tetrabutylammonium in (18)f-labeled radiopharmaceuticals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035771/ https://www.ncbi.nlm.nih.gov/pubmed/24830987 http://dx.doi.org/10.3390/ph7050621 |
work_keys_str_mv | AT kuntzschmatthias developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals AT lamparterdenis developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals AT bruggenernils developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals AT mullermarco developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals AT kienzlegabrielej developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals AT reischlgerald developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals |